Answer
The most frequently reported side effects of Abrysvo in pregnant women studied at 24–36 weeks of gestation were vaccination site pain (41%), headache (31%) and muscle pain (27%), with most local and systemic reactions mild to moderate and resolving within 2–3 days of onset.
Sources for this answer
- Abrysvo powder and solvent for solution for injectionPfizer Limited · emc · SmPC §4.8 Undesirable effects · Version 13Document updated
Sources checked